|
⚲
|
| Keyboard |
| Shirvan Mitchell
✚
|
|
|---|---|
| CIK # | 0001727789 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001727789] | |
| 4 | [0001727789] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Silexion Therapeutics Corp | |
| Shirvan Mitchell | |
| Foamix Pharmaceuticals Ltd |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Silexion Therapeutics Corp SLXN
Ordinary Shares
|
2026-03-26 | Sell | 22,818 | $1.36 | 31,032 |
|
Silexion Therapeutics Corp SLXN
Ordinary Shares
|
2026-02-20 | Grant | 49,726 | $0.00 | |
|
Foamix Pharmaceuticals Ltd FOMX
Ordinary Shares
|
2018-02-27 | Grant | 5,000 | $0.00 | |
|
Foamix Pharmaceuticals Ltd FOMX
Options · derivative
|
2018-02-27 | Grant | 15,000 | $6.40 | 96,000 |
|
Foamix Pharmaceuticals Ltd FOMX
Ordinary Shares
|
2018-01-15 | Option exercise | 562 | $0.00 | |
|
Foamix Pharmaceuticals Ltd FOMX
Restricted Share Units · derivative
|
2018-01-15 | Option exercise | 562 | $0.00 | |
|
Foamix Pharmaceuticals Ltd FOMX
Ordinary Shares
|
2018-01-01 | Option exercise | 2,745 | $0.00 | |
|
Foamix Pharmaceuticals Ltd FOMX
Restricted Share Units · derivative
|
2018-01-01 | Option exercise | 2,745 | $0.00 |